secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001437749-25-036573
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders re-elect director, approve 3-year say-on-pay frequency, ratify auditor
--------------------------------------------------------------------------------

- Eric Friedman re-elected as Class III director with 20.66M votes for, 183k withheld, and 1.81M broker non-votes.
- Non-binding advisory vote: 20.40M shares favor 3-year frequency for executive compensation votes.
- Executive compensation say-on-pay approved: 20.79M for, 56,978 against, 700 abstain.
- Ratification of CBIZ CPAs P.C. as independent auditors for FY2026: 22.54M for, 113k against, 1,138 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/0001437749-25-036573-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/inbp20251201_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036573

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer